September 1, 2015 / 5:21 AM / 2 years ago

Swiss stocks - Factors to watch on Sept. 1

ZURICH, Sept. 1 (Reuters) - The Swiss blue-chip SMI was seen opening nearly 1 percent down at 8737.53 points on Tuesday, according to premarket indications by bank Julius Baer .

The following are some of the main factors expected to affect Swiss stocks:

Syngenta

The Swiss crop chemicals maker said it has won U.S. approval for its fungicide solatenol, adding global peak sales could reach $1 billion.

For more click on

Novartis

The drugmaker said it received EU approval for Tafinlar and Mekinist, the first combination approved for patients with an aggressive form of melanoma.

For more click

COMPANY STATEMENTS

** UBS Group said it has completed its SESTA procedure and will pay a supplementary dividend of 0.25 Swiss francs on Sept. 22. It's also starting a new marketing campaign with celebrity photographer Anne Leibowitz.

** Alpiq sold its 26 percent share of Gommmerkraftwerke AG to Group E in western Switzerland. The Swiss power producer didn't release the price of the transaction.

** Leclanche says it won a "major order" for solar street lighting solutions in Saudi Arabia and a new battery order for automatic-guided vehicles.

** Helvetia Holdings AG says its combined ratio in the first half of 2015 was 92.4 percent, compared to 94 percent in the first half of last year.

** Hiag said it had net income in the first half of 24.2 million Swiss francs ($25.17 million) and that its operating income rose 9 percent.

** Romande Energie boosted its gross profit by 4 percent and expects to achieve a full-year business performance in line with the first six months of the year, not including exceptional items.

ECONOMY

The Swiss manufacturing PMI is due at 0730 GMT. ($1 = 0.9615 Swiss francs) (Reporting by Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below